Literature DB >> 460539

LH release and ovulation in the rat following depletion of hypothalamic norepinephrine: chronic vs. acute effects.

D K Clifton, C H Sawyer.   

Abstract

The effects of long-term hypothalamic norepinephrine (NE) depletion on reproductive cyclicity, ovulation, and luteinizing hormone (LH) release were studied in adult female rats. Bilateral transections of the ascending noradrenergic pathway (ANP) at the level of the mesencephalon led to an 83% depletion of hypothalamic NE. Although some animals exhibited a period of acyclicity following this surgical procedure, by 23 days all animals had begun to cycle. When checked for ovulation at around 40 days, all of the rats had shed full quotas of ova. There was no significant difference in either the timing or magnitude of the surge when proestrous LH levels in NE-depleted rats were compared with sham transected controls. To see if the residual hypothalamic NE left after transection of the ascending noradrenergic pathway was important for maintenance of normal LH secretion and ovulation, a group of long-term depleted rats were given an NE synthesis inhibitor (diethyldithiocarbamate: DDC). In all of the sham-cut and intact control rats this drug either partially or completely blocked ovulation, but it was effective in only 40% of the depleted animals. The other 60% not only ovulated, but shed full quotas of ova. These results demonstrate that normal LH secretion can occur even when hyplthalamic NE levels are extremely low. Although acute depressions of NE by pharmacological agents such as DDC effectively block the LH surge, this inhibition is not sustained when NE is depleted over long periods of time. Therefore, NE apparently plays a modulatory, rather than mandatory, role in control of LH release and ovulation.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 460539     DOI: 10.1159/000122893

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  7 in total

1.  Definition of brainstem afferents to gonadotropin-releasing hormone neurons in the mouse using conditional viral tract tracing.

Authors:  Rebecca E Campbell; Allan E Herbison
Journal:  Endocrinology       Date:  2007-09-06       Impact factor: 4.736

2.  The role of kisspeptin-GPR54 signaling in the tonic regulation and surge release of gonadotropin-releasing hormone/luteinizing hormone.

Authors:  Heather M Dungan; Michelle L Gottsch; Hongkui Zeng; Alexander Gragerov; John E Bergmann; Demetrios K Vassilatis; Donald K Clifton; Robert A Steiner
Journal:  J Neurosci       Date:  2007-10-31       Impact factor: 6.167

3.  Norepinephrine suppresses gonadotropin-releasing hormone neuron excitability in the adult mouse.

Authors:  Seong-Kyu Han; Allan E Herbison
Journal:  Endocrinology       Date:  2007-12-13       Impact factor: 4.736

4.  Influence of norepinephrine administration upon pituitary hormone secretion in normal men.

Authors:  G N Mileikowsky; R M Farmer; V De Quattro; O A Kletzky
Journal:  J Endocrinol Invest       Date:  1988-10       Impact factor: 4.256

5.  Redundancy in Kiss1 expression safeguards reproduction in the mouse.

Authors:  Simina M Popa; Ryutaro M Moriyama; Claudia S Caligioni; Jasmine J Yang; Caroline M Cho; Tessa L Concepcion; Amy E Oakley; In Hae Lee; Elisenda Sanz; Paul S Amieux; Alain Caraty; Richard D Palmiter; Victor M Navarro; Yee-Ming Chan; Stephanie B Seminara; Donald K Clifton; Robert A Steiner
Journal:  Endocrinology       Date:  2013-06-04       Impact factor: 4.736

6.  Neuro-pharmacological reinstatement of ovulation and associated neurobiology in a macaque model of functional hypothalamic amenorrhoea.

Authors:  Cynthia L Bethea; Judy L Cameron
Journal:  Hum Reprod       Date:  2021-01-01       Impact factor: 6.918

7.  Kisspeptin/Neurokinin B/Dynorphin (KNDy) cells as integrators of diverse internal and external cues: evidence from viral-based monosynaptic tract-tracing in mice.

Authors:  Aleisha M Moore; Lique M Coolen; Michael N Lehman
Journal:  Sci Rep       Date:  2019-10-14       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.